CMMB Q1 2023 Earnings — Chemomab Therapeutics Ltd. Revenue & Financial Results | Market Cap Arena

CMMBChemomab Therapeutics Ltd.

$12M

Q1 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$9M

Operating Income

-$9M

Net Income

-$9M

EPS (Diluted)

$-3.14

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$35M

Total Liabilities

$7M

Stockholders' Equity

$28M

Cash & Equivalents

$21M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$9M	-$13,028	-69358.1%
Operating Income	-$9M	-$5M	-70.4%
Net Income	-$9M	-$5M	-71.5%